Solventum Co. (NYSE:SOLV – Get Free Report) has earned a consensus recommendation of “Hold” from the ten analysts that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and one has issued a buy rating on the company. The average 1-year price target among analysts that have covered the stock in the last year is $68.00.
SOLV has been the subject of a number of recent analyst reports. Wolfe Research started coverage on Solventum in a research report on Thursday, September 26th. They issued a “peer perform” rating for the company. Piper Sandler lifted their target price on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. The Goldman Sachs Group upped their price target on shares of Solventum from $48.00 to $54.00 and gave the stock a “sell” rating in a research report on Monday, August 12th. Stifel Nicolaus began coverage on Solventum in a report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price objective on the stock. Finally, Wells Fargo & Company cut their price objective on Solventum from $69.00 to $64.00 and set an “equal weight” rating for the company in a research note on Friday, August 9th.
Solventum Trading Up 2.0 %
Institutional Investors Weigh In On Solventum
Several hedge funds and other institutional investors have recently made changes to their positions in SOLV. MML Investors Services LLC boosted its stake in Solventum by 3.2% in the third quarter. MML Investors Services LLC now owns 5,345 shares of the company’s stock valued at $373,000 after acquiring an additional 168 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. boosted its position in shares of Solventum by 4.2% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,966 shares of the company’s stock valued at $346,000 after purchasing an additional 200 shares during the period. National Bank of Canada FI grew its stake in Solventum by 4.0% during the 2nd quarter. National Bank of Canada FI now owns 6,093 shares of the company’s stock worth $314,000 after buying an additional 236 shares during the last quarter. IVC Wealth Advisors LLC increased its position in Solventum by 5.0% during the third quarter. IVC Wealth Advisors LLC now owns 6,649 shares of the company’s stock worth $464,000 after buying an additional 318 shares during the period. Finally, KKM Financial LLC lifted its stake in Solventum by 7.9% in the third quarter. KKM Financial LLC now owns 4,367 shares of the company’s stock valued at $304,000 after buying an additional 319 shares during the last quarter.
About Solventum
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
See Also
- Five stocks we like better than Solventum
- What Investors Need to Know to Beat the Market
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Williams-Sonoma Stock: Buy It and Never Let It Go
- What Investors Need to Know About Upcoming IPOs
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.